Hartford Investment Management Co. Sells 148 Shares of The Clorox Company (NYSE:CLX)

Hartford Investment Management Co. trimmed its position in The Clorox Company (NYSE:CLX) by 1.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 7,641 shares of the company’s stock after selling 148 shares during the quarter. Hartford Investment Management Co.’s holdings in Clorox were worth $1,241,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the company. Insight Folios Inc increased its position in Clorox by 3.0% during the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after purchasing an additional 63 shares during the period. HCR Wealth Advisors grew its holdings in shares of Clorox by 1.0% during the fourth quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after buying an additional 68 shares during the last quarter. Empower Advisory Group LLC increased its position in shares of Clorox by 4.5% in the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after acquiring an additional 78 shares during the period. Aviance Capital Partners LLC raised its stake in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after acquiring an additional 80 shares during the last quarter. Finally, Lindbrook Capital LLC lifted its position in Clorox by 9.9% during the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after acquiring an additional 88 shares during the period. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Price Performance

Shares of Clorox stock opened at $147.91 on Friday. The firm has a market cap of $18.31 billion, a PE ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $171.37. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The business has a 50-day moving average price of $159.55 and a 200 day moving average price of $159.13.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the firm earned $2.16 earnings per share. Sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th were given a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.30%. Clorox’s dividend payout ratio (DPR) is 133.33%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Barclays lifted their price objective on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and boosted their target price for the company from $155.00 to $170.00 in a research report on Wednesday, November 6th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.